Millennium Management’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$231K Buy
20,396
+776
+4% +$8.81K ﹤0.01% 3656
2025
Q1
$130K Sell
19,620
-57,209
-74% -$380K ﹤0.01% 3716
2024
Q4
$847K Buy
76,829
+61,994
+418% +$684K ﹤0.01% 2987
2024
Q3
$182K Sell
14,835
-274,232
-95% -$3.37M ﹤0.01% 3756
2024
Q2
$3.91M Buy
289,067
+243,083
+529% +$3.28M ﹤0.01% 2080
2024
Q1
$621K Buy
45,984
+22,070
+92% +$298K ﹤0.01% 3207
2023
Q4
$126K Sell
23,914
-251,425
-91% -$1.32M ﹤0.01% 3649
2023
Q3
$1.08M Sell
275,339
-179,776
-40% -$708K ﹤0.01% 2873
2023
Q2
$4.84M Buy
455,115
+287,586
+172% +$3.06M ﹤0.01% 1968
2023
Q1
$1.4M Sell
167,529
-251,650
-60% -$2.1M ﹤0.01% 2797
2022
Q4
$3.87M Sell
419,179
-236,770
-36% -$2.19M ﹤0.01% 2281
2022
Q3
$8.42M Sell
655,949
-293,709
-31% -$3.77M 0.01% 1756
2022
Q2
$12.5M Buy
949,658
+521,661
+122% +$6.89M 0.01% 1290
2022
Q1
$9.01M Buy
427,997
+278,372
+186% +$5.86M ﹤0.01% 1713
2021
Q4
$3.59M Buy
149,625
+94,800
+173% +$2.27M ﹤0.01% 2503
2021
Q3
$1.4M Buy
+54,825
New +$1.4M ﹤0.01% 3353
2021
Q2
Sell
-79,477
Closed -$3.09M 5335
2021
Q1
$3.09M Buy
+79,477
New +$3.09M ﹤0.01% 2500
2020
Q3
Sell
-254,229
Closed -$6.06M 3886
2020
Q2
$6.06M Buy
254,229
+140,736
+124% +$3.35M 0.01% 1260
2020
Q1
$2.6M Sell
113,493
-208,888
-65% -$4.78M 0.01% 1472
2019
Q4
$9.13M Sell
322,381
-375,430
-54% -$10.6M 0.01% 1160
2019
Q3
$15M Buy
697,811
+145,081
+26% +$3.12M 0.02% 784
2019
Q2
$16.1M Buy
+552,730
New +$16.1M 0.02% 784